https://www.thetimes.co.uk/article/investors-back-potential-drug-for-diabetic-covid-19-patients-06dm22 Nov 2020 16:14
project to develop a potential coronavirus treatment for diabetics, headed by Sir Christopher Evans, one of Britain’s leading biotechnology entrepreneurs, has raised £10 million from investors and has begun an advanced clinical trial.
The phase two trial, called Arcadia, involving 150 patients in 30 hospitals in Britain, began at the weekend after approval was granted by the Medicines and Healthcare product Regulatory Agency. Pre-clinical research has suggested that the glucose kinase activator could aid diabetes sufferers who contract Covid-19.